Histamine Inhibits Tumor Necrosis Factor α Release by Mast Cells through H2 and H3 Receptors

American Journal of Respiratory Cell and Molecular Biology

Volumn 14, Issue 6, 1996, Pages 620-626

  Bissonnette, Elyse Y ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYTOTOXIN; FORSKOLIN; HISTAMINE; HISTAMINE H2 RECEPTOR; HISTAMINE H3 RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ANTIBODY SPECIFICITY; ARTICLE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; IMMUNOLOGY; MALE; MAST CELL; PERITONEUM MACROPHAGE; PHYSIOLOGY; RAT; SECRETION; SENSITIVITY AND SPECIFICITY; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; ANTIBODY SPECIFICITY; CYCLIC AMP; CYCLOOXYGENASE INHIBITORS; CYTOTOXINS; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FORSKOLIN; HISTAMINE; MACROPHAGES, PERITONEAL; MALE; MAST CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, HISTAMINE H2; RECEPTORS, HISTAMINE H3; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030161405     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.14.6.8652190     Document Type: Article

References (45)

1. Broide, D. H., G. J. Gleich, A. J. Cuomo, D. A. Coburn, E. C. Federman, L. B. Schwartz, and S. I. Wasserman. 1991. Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway. J. Allergy Clin. Immunol. 88:637-648.
2. Barnes, P. J. 1994. Cytokines as mediators of chronic asthma. Am. J. Respir. Crit. Care Med. 150:S42-S49.
3. White, M. V., J. E. Slater, and M. A. Kaliner. 1987. Histamine and asthma. Am. Rev. Respir. Dis. 135:1165-1176.
4. Falus, A. 1994. Inflammation: the role of histamine. In Histamine and Inflammation. A. Falus, editor. R. G. Landes Company, Georgetown, TX. 63-77.
5. Panettieri, R. A., P. A. Yadvish, A. M. Kelly, N. A. Rubinstein, and M. I. Kotlikoff. 1990. Histamine stimulates proliferation of airway smooth muscle and induces c-fos expression. Am. J. Physiol. 259:L365-L371.
6. Falus, A., and K. Merétey. 1992. Histamine: an early messenger in inflammatory and immune reactions. Immunol. Today 13:154-156.
7. Rocklin, R. E. 1977. Histamine-induced suppressor factor (HSF): effect on migration inhibitory factor (MIF) production and proliferation. J. Immunol. 118:1734-1738.
8. 2 histamine receptors. Immunology 41:107-112.
9. Barsoum, I. S., H. S. S. Dahawi, F. M. Gamil, M. Habib, M. A. El Alamy, and D. G. Colley. 1984. Immune responses and immunoregulation in relation to human schistosomiasis in Egypt. II. Cimetidine reversal of histamine-mediated suppression of antigen-induced blastogenesis. J. Immunol. 133:1576-1580.
10. Beer, D. J., S. M. Matloff, and R. E. Rocklin. 1984. The influence of histamine on immune and inflammatory responses. Adv. Immunol. 35:209-269.
11. Dohlsten, M., H. O. Sjogren, and R. Carlsson. 1987. Histamine acts directly on human T cells to inhibit interleukin-2 and interferon-gamma production. Cell. Immunol. 109:65-74.
12. Dohlsten, M., T. Kalland, H. O. Sjogren, and R. Carlsson. 1988. Histamine inhibits interleukin 1 production by lipopolysaccharide-stimulated human peripheral blood monocytes. Scand. J. Immunol. 27:527-532.
13. Hotermans, G., T. Bury, and M. F. Radermecker. 1991. Effect of histamine on tumor necrosis factor production by human monocytes. Int. Arch. Allergy Appl. Immunol. 95:278-281.
14. 2 receptors. J. Exp. Med. 174:281-284.
15. Hill, S. J. 1990. Distribution, properties, and functional characteristics of three classes of histamine receptor. Pharmacol. Rev. 42:45-83.
16. 3 receptors inhibit cholinergic neurotransmission. J. Pharmacol. Exp. Ther. 258:325-331.
17. 3-receptors. Nature 327:117-123.
18. 3) of histamine receptors on perivascular nerve terminals. Nature 327:158-160.
19. Holgate, S. T., and A. B. Kay. 1985. Mast cells, mediators and asthma. Clin. Allergy 15:221-234.
20. Leung, K. P. B., K. C. Flint, B. N. Hudspith, J. Brostoff, N. M. Johnson, K. Seager, M. D. Hammond, and F. L. Pearce 1987. Some further properties of human pulmonary mast cells recovered by bronchoalveolar lavage and enzymatic dispersion of lung tissue. Agents Actions 20:213-215.
21. Gordon, J. R., and S. J. Galli. 1990. Mast cells as a source of both preformed and immunologically inducible-TNF-α/cachectin. Nature 346: 274-277.
22. Stricter, R. M., S. L. Kunkel, and R. C. Bone. 1993. Role of tumor necrosis factor-alpha in diseuse states and inflammation. Crit. Care Med. 21:S447-S463.
23. Cromwell, O., Q. Hamid, C. J. Corrigan, J. Barkans, Q. Meng, P. D. Collins, and A. B. Kay. 1992. Expression and generation of interleukin-8, IL-6 and granulocytc-macrophage colony-stimulating factor by bronchial epithelial cells and enhancement by IL-1 beta and tumour necrosis factor alpha. Immunology 77:330-337.
24. Tosi, M. F., J. M. Stark, C. W. Smith, A. Hamedani, D. C. Gruenert, and M. D. Infeld. 1992. Induction of ICAM-1 expression on human airway epithelial cells by inflammatory cytokines: effects on neutrophil-epithelial cell adhesion. Am. J. Respir. Cell Mol. Biol. 7:214-221.
25. Kips, J. C., J. H. Tavernier, G. F. Joos, R. A. Peleman, and R. A. Pauwels. 1993. The potential role of tumour necrosis factor α in asthma. Clin. Exp. Allergy 23:247-250.
26. Thomas, P. S., D. H. Yates, and P. J. Barnes. 1995. Tumor necrosis factor-α increases airway responsiveness and sputum neutrophilia in normal human subjects. Am. J. Respir. Crit. Care Med. 152:76-80.
27. Herberman, R. B., J. R. Ortaldo, J. Y. Djeu, H. T. Holden, J. Jett, N. P. Lang, M. Rubinstein, and S. Pestka. 1980. Role of interferon in regulation of cytotoxicity by natural killer cells and macrophages. Ann. N.Y. Acad. Sci. 350:63-71.
28. Bissonnette, E. Y., and A. D. Befus. 1990. Inhibition of mast cell-mediated cytotoxicity by IFN-α/β and -γ. J. Immunol. 145:3385-3390.
29. Befus, A. D., N. Johnston, and J. Bienenstock. 1979. Nippostrongylus brasiliensis: mast cells and histamine levels in tissues of infected and normal rats. Exp. Parasitol. 48:1-8.
30. Lee, T. D. G., F. Shanahan, H. R. P. Miller, J. Bienenstock, and A. D. Befus. 1985. Intestinal mucosal mast cells: isolation from rat lamina propria and purification using unit gravity velocity sedimentation. Immunology 55:721-728.
31. Pross, H. F., M. G. Baines, P. Rubin, P. Shragge, and M. S. Patterson. 1981. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantification of natural killer activity. J. Clin. Immunol. 1:51-63.
32. 3H]thymidine incorporation assay. J. Immunol. Methods 170:211-224.
33. Sette, A., L. Adorni, E. Mambini, and G. Doria. 1986. A microcomputer program for probit analysis of interleukin-2 (IL-2) titration data. J. Immunol. Methods 86:265-277.
34. Befus, A. D., J. Bienenstock, and J. A. Denburg. 1986. Mast Cell Differentiation and Heterogeneity. Raven Press, New York.
35. Goto, T., D. Befus, R. Low, and J. Bienenstock. 1984. Mast cell heterogeneity and hyperplasia in bleomycin-induced pulmonary fibrosis of rats. Am. Rev. Respir. Dis. 130:797-802.
36. Tomioka, M., T. Goto, T. D. G. Lee, J. Bienenstock, and A. D. Befus. 1989. Isolation and characterization of lung mast cells from rats with bleomycin-induced pulmonary fibrosis. Immunology 66:439-444.
37. 3-receptors in the regulation of anaphylactic histamine release from isolated rat peritoneal mast cells. Jpn. J. Pharmacol. 66:173-180.
38. Staszak, C., and J. S. Goodwin. 1980. Is prostaglandin a mediator for the inhibitory action of histamine, hydrocortisone, and isoproterenol? Cell. Immunol. 54:351-361.
39. Phipps, R. P., S. H. Stein, and R. L. Roper. 1991. A new view of prostaglandin E regulation of the immune response. Immunol. Today 12:349-352.
40. Hogaboam, C. M., E. Y. Bissonnette, B. C. Chin, A. D. Befus, and J. L. Wallace. 1993. Prostaglandins inhibit inflammatory mediator release from rat mast cells. Gastroenterology 104:122-129.
41. Jun, T.-J., E. Y. Bissonnette, and A. D. Befus. 1996. Cytokine and drug modulation of TNFα in mast cells. In Molecular Biology of Allergens and the Atopic Immune Response. A. Sehon and D. Kraft, editors. Plenum Publishing Corporation, New York. (In press)
42. 2 receptor mediated inhibition of immediate type hypersensitivity reactions in vivo. Am. Rev. Respir. Dis. 117:479-484.
43. Bury, T. B., J. L. Corhay, and M. P. Radermecker. 1992. Histamine-induced inhibition of neutrophil chemotaxis and T-lymphocyte proliferation in man. Allergy 47:624-629.
44. Bhat, K. N., C. M. Arroyave, S. R. Marney, D. D. Stevenson, and E. M. Tan. 1976. Plasma histamine changes during provoked bronchospasm in asthmatic patients. J. Allergy Clin. Immunol. 58:647-656.
45. Beer, D. J., M. E. Osband, R. P. McCaffrey, N. A. Soter, and R. E. Rocklin. 1981. Abnormal histamine-induced suppressor-cell function in atopic subjects. N. Engl. J. Med. 306:454-458.